BIOMAT Database Logo BIOMAT Database Logo

[Effect of inducers and inhibitors of mixed function oxidases on body resistance to endotoxins of gram-negative bacteria]. 1989

M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev

Experimental typhoid intoxication in white mice leads to the inhibition of microsomal oxidation in the liver, which is manifested by the prolongation of hexenal-induced sleep and a decrease in the toxic action of parathion. Phenobarbital, capable of inducing oxidases with mixed function (OMF), enhances the process of the detoxification of endotoxin injected into the animals, which is manifested by the increase of its LD50. Soluble levomycetin succinate, widely used for the treatment of typhoid-paratyphoid infections, is a powerful inhibitor of OMF (as shown by the hexenal test). Benzonal, the analog of phenobarbital, removes the inhibitory effect of the antibiotic. Experimental studies carried out in the course of this investigation make it possible to substantiate the clinical trial of these preparations (OMF inducers) used in the complex therapy of typhoid-paratyphoid infections for the stimulation of natural detoxification mechanisms of the body. Benzonal is the preparation of choice for use in clinical practice.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D010278 Parathion A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide. E-605,Ethyl Parathion,Phosphostigmine,Thiofos,Thiophos,Parathion, Ethyl
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001463 Barbiturates A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.

Related Publications

M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
The endotoxins of gram-negative bacteria and host resistance.
May 1961, The New England journal of medicine,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
The endotoxins of gram-negative bacteria and host resistance.
May 1961, The New England journal of medicine,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Endotoxins of Gram-negative bacteria.
January 1981, Pharmacology & therapeutics,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Initial responses to endotoxins and Gram-negative bacteria.
September 2002, Clinica chimica acta; international journal of clinical chemistry,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Endotoxins: lipopolysaccharides of gram-negative bacteria.
January 2010, Sub-cellular biochemistry,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Endotoxins of gram-negative anaerobic bacteria.
January 1980, Infection,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
[Endotoxins of gram-negative bacteria: chemical structure and biological effect].
September 1986, Zeitschrift fur Gastroenterologie,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Metabolism in vivo of dioxane: effect of inducers and inhibitors of hepatic mixed-function oxidases.
August 1977, Biochemical pharmacology,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
[Histamine-increasing effect of endotoxins from various gram-negative bacteria].
September 1965, Klinische Wochenschrift,
M N Liniuchev, and T M Zubik, and A Iu Kovelenov, and V I Bulyko, and V V Sergeev
Effect of spaceflight on ability of monocytes to respond to endotoxins of gram-negative bacteria.
October 2008, Clinical and vaccine immunology : CVI,
Copied contents to your clipboard!